India to Australia: Loperamide Export Trade Route

The India to Australia Loperamide corridor is one of India's established pharmaceutical export routes, with 220 shipments documented worth a combined $2.4M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 29% of all export value, reflecting the consolidated nature of India's loperamide manufacturing sector.

Across 21 active suppliers, the average shipment value stands at $10.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with loperamide's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 24 days port-to-port. The route has recorded an annual growth rate of 13.1%, placing it at rank #6 among India's top loperamide export destinations globally.

On the import side, key buyers of Indian loperamide in Australia include MEDREICH AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LTD, ASPEN PHARMACARE AUSTRALIA PTY LIMITED and 30 others. MEDREICH AUSTRALIA PTY LTD is the single largest importer with 56 shipments valued at $531.6K USD.

India's loperamide exports to Australia are driven primarily by a handful of large-scale manufacturers. MEDREICH LIMITED with 74 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 21 active exporters signals a competitive but concentrated market — buyers in Australia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MEDREICH LIMITED, SHARON BIO-MEDICINE LIMITED, SHARON BIO MEDICINE LIMITED — together account for 66% of total trade value on this route. The average shipment value of $10.8K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as loperamide hydrochloride 2mg capsules (g and gastro stop 2mg capsules otc-01x08'sloperamide 2mg capsule batch no. akx3023b manufacturing .dt.09/2023 exp.dt:08/2025, suggesting that buyers in Australia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MEDREICH AUSTRALIA PTY LTD is the largest importer with 56 shipments worth $531.6K USD — representing 22% of all loperamide imports from India on this route. A total of 33 buyers are active on this corridor.